News
-
-
-
-
-
-
-
-
PRESS RELEASE
Corrected press release : THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protecting the Use of Batten-1 in Juvenile Batten Disease (CLN3)
THX Pharma and Beyond Batten Disease Foundation secure European patent EP 4 188 371 for Batten-1 in juvenile Batten disease (CLN3), reinforcing long-term exclusivity strategy -
-